, July 2019 — Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. European Journal of Pharmacology vol. 854, , dir. {Elsevier} p. 398-405
, February 2020 — Expression analysis data of BCL11A and \gamma-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data in Brief vol. 28, , dir. {Elsevier} p. 104974
, October 2007 — Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action.. Proceedings of the National Academy of Sciences of the United States of
America vol. 104, n° 44, dir. {National Academy of Sciences} p. 17347-52
, December 2017 — HuR-Dependent Editing of a New Mineralocorticoid Receptor Splice Variant Reveals an Osmoregulatory Loop for Sodium Homeostasis. Scientific Reports vol. 7, n° 1, dir. {Nature Publishing Group} p. 4835
, December 2017 — RNA-binding protein HuR enhances mineralocorticoid signaling in renal KC3AC1 cells under hypotonicity. Cellular and Molecular Life Sciences vol. 74, n° 24, dir. {Springer Verlag} p. 4587-4597
, September 2014 — Hypertonicity Compromises Renal Mineralocorticoid Receptor Signaling through Tis11b-Mediated Post-Transcriptional Control. Journal of the American Society of Nephrology vol. 25, n° 10, dir. {American Society of Nephrology} p. 2213-2221
, February 2019 — UCP1 transrepression in Brown Fat in vivo and mineralocorticoid receptor anti-thermogenic effects. Annales d’Endocrinologie vol. 80, n° 1, dir. {Elsevier Masson} p. 1-9
, December 2016 — The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1. Molecular Biology of the Cell vol. 27, n° 24, dir. {American Society for Cell Biology} p. 3841-3854
, June 2007 — Fluorescence-based melting assays for studying quadruplex ligands.. Methods vol. 42, n° 2, dir. {Elsevier} p. 183-95
, December 2019 — Functional interplay between TFIIH and KAT2A regulates higher-order chromatin structure and class II gene expression. Nature Communications vol. 10, n° 1, dir. {Nature Publishing Group} p. 1288
, 2018 — CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair. Nature Communications vol. 9, n° 1, dir. {Nature Publishing Group}
, August 2018 — Cooperation, cis-interactions, versatility and evolutionary plasticity of multiple cis-acting elements underlie krox20 hindbrain regulation. PLoS Genetics vol. 14, n° 8, dir. {Public Library of Science} e1007581
, July 2020 — Characterization of post-edited cells modified in the TFAM gene by CRISPR/Cas9 technology in the bovine model. PLoS ONE vol. 15, n° 7, dir. {Public Library of Science} e0235856
, November 2008 — Targeting of \beta-Arrestin2 to the Centrosome and Primary Cilium: Role in Cell Proliferation Control. PLoS ONE vol. 3, n° 11, dir. {Public Library of Science} e3728
, October 2021 — Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective. Human Gene Therapy vol. 32, 19-20, dir. {Mary Ann Liebert} p. 1059-1075
, February 2012 — ATP-Independent Cooperative Binding of Yeast Isw1a to Bare and Nucleosomal DNA. PLoS ONE vol. 7, n° 2, dir. {Public Library of Science} e31845
, January 2020 — Heat Shock Factor 2 Protects against Proteotoxicity by Maintaining Cell-Cell Adhesion. Cell Reports vol. 30, n° 2, dir. {Elsevier Inc} 583-597.e6
, December 2019 — A novel lineage of candidate pheromone receptors for sex communication in moths. eLife vol. 8, , dir. {eLife Sciences Publication}
, July 2020 — Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature Communications vol. 11, n° 1, dir. {Nature Publishing Group} p. 3778
, November 2019 — Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9. Animal Model Exp Med / Animal models and experimental medicine. vol. 2, n° 4, dir. {[Hoboken, New Jersey] : John Wiley \& Sons, Inc., [2018]-} p. 297-311